Fifth Annual Cancer Control Symposium: Personalized Approaches in Cancer Prevention & Screening to Improve Health

In efforts to prevent the transmission of COVID-19, this conference has been cancelled.  Please check back at a later date for information on the possible rescheduling of this activity later this year. All current registrations will be refunded within 3-5 business days.

Friday, March 13, 2020
Renaissance Seattle Hotel
515 Madison St
Seattle, Washington 98104

Swedish Cancer Institute’s Fifth Annual Cancer Control Symposium will feature didactic lectures and discussions about the factors that impact efforts for an increasingly more personalized approach to cancer prevention & screening. Expert faculty will review the most current research and evidence-based interventions, to help guide our community in efforts to increase screening rates, and to lessen the impact of risk-factors for cancer. Specifically, this course will feature lectures focused on hereditary cancers, consumer genomics, lung cancer screening, gastric cancer prevention, psychosocial factors, and shared decision-making.

This conference is intended for all health-care professionals involved in the care of cancer patients and those at risk, including physicians, ARNPs, PAs, nurses, pharmacists, allied health professionals, administrative leaders, community program managers, patient health advocates, residents/fellows and researchers. It is especially relevant for the following specialties: medical oncology, radiation oncology, surgical oncology, genetic counseling, family medicine, internal medicine, primary care, research, palliative care, community public health, supportive care services, and social work.


Diana S.M. Buist, Ph.D.
Director of Research and Strategic Partnerships
Senior Investigator
Kaiser Permanente Washington Health Research Institute

Karen Hurley, Ph.D.
Center for Behavioral Health
The Cleveland Clinic

Kunjali Padhya, M.D.
Swedish Medical Group

Robert Resta, MS, CGC
Genetic Counselor
Swedish Cancer Institute

Karen Wernli, Ph.D.
Cancer Epidemiologist
Associate Investigator, Health Services
Kaiser Permanente Washington Health Research Institute

Candice Wilshire, M.D.
Research Program Director
The Center for Lung Research in Honor of Wayne Gittinger
Swedish Cancer Institute

Community Panelists:

Karen Boudour, ARNP
Pediatric Nurse Practitioner
Ballard High School and The Center School Teen Health Districts
Swedish Medical Center

Elizabeth Crouch
Health Instructor
the Rivkin Center

Kiran Dhillon
Director of Scientific Programs
the Rivkin Center

James Myers
HPV Vaccine Peer Educator (former)
The Center School, Class of 2019

Swedish CME maintains full control of the content of every course we provide. It is our policy to identify and resolve all speaker and planner conflicts of interest. Each speaker is required to give a balanced, evidence-based presentation that is free of commercial bias.

Planning Committee

Somasundaram Subramaniam, M.D., MS, Course Director
Gary Goodman, M.D., MS
Nancy Hanson, MS, GC
Paul Kilian, MBA
Barbara Kollar, MHA, MCHES
Cecilia Lynn, ARNP
Nancy Thompson, RN, MSN, AOCNS
Kathleen To
Kristin Wisegarver, MHA
Danielle Posadas, CME Specialist Sr.



At the conclusion of this symposium, the participant will provide better patient care through an increased ability to:

Overall Course

  • Influence clinical change by recognizing how behavioral outcomes of uptake, adherence, and impact influence the prevention goals of reducing morbidity and mortality.
  • Review the current state of screening for lung cancer, including demographics, risk factors, barriers to screening, shared decision-making and follow-up. 
  • Identify the many differences between direct-to-consumer and professional genomic testing, in order to best guide patients who have consumer results or are seeking counseling/testing. 
  • Provide the latest information to patients on surveillance, prevention and screening for gastric cancers.
  • Use community and organizational resources to reduce barriers to cancer prevention (such as culture, language, location, and cost).

Lecture Specific Objectives

  • Identify health behavior translational outcomes (uptake, adherence, impact) that influence the morbidity/mortality benefits of advances in cancer control and apply health behavior translational framework to identify research questions in clinical care settings and to reduce the effects of these factors and barriers
  • Name different types of consumer genomic testing, identify the clinical utility of different types of consumer genomic testing, and refer appropriate patients for genetic counseling who have undergone genetic testing
  • Review the factors that affect cancer screening access and prevention adherence in our communities with experts and discuss oncology screening related questions from everyday practice with experts
  • Describe the socioeconomic demographics of individuals currently undergoing lung cancer screening within the Pacific NW; discuss the distribution and correlation of lung cancer screening sites to individuals eligible for lung cancer screening, as well as those individuals at highest risk for lung cancer; and review the tools to assist in bridging the gap in access to lung cancer screening
  • Articulate different sources of lung cancer screening guidelines and discuss when to include patients in the decision of whether screening for cancer should be done
  • Review current adherence rates to repeat LDCT screening, recognize the importance repeat screening has to achieve lung cancer mortality benefit observed in large clinical trials, and identify key barriers and facilitators to screening from multiple stakeholder perspectives
  • Review the pathology and natural history of gastric cancer, identify high-risk populations and conditions predisposing to gastric cancer, and refer appropriate patients for gastric cancer screening
  • Discuss the current state of cancer screenings in our communities with local experts and apply strategies on a local, community level to address barriers to adherence with cancer screening and prevention recommendations


Accreditation with Commendation
Swedish Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA PRA Category 1 Credits
Swedish Medical Center designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
AMA PRA Category 1 Credits™ are accepted for Washington State RN Continuing Education requirements as well as for application and renewal of specialty and advance practice certification through both ANCC and AANP (1 CNE hour is equivalent to 1 CME hour).

Genetic Counselor CEUs
Genetic Counselor CEUs: This event has been submitted to the National Society of Genetic Counselors (NSGC) for approval of Category 1 CEUs. The American Board of Genetic Counseling (ABGC) accepts CEUs approved by NSGC for purposes of recertification. Approval for the requested CEUs and Contact Hours is currently pending.

National Commission for Health Education Credentialing - Health Education CECHs
Sponsored by Swedish Medical Center, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 5.5 total Category I continuing education contact hours. Maximum advanced-level CECH available are 5.5. Continuing Competency credits available are 0.0. Provider ID# 101907.


Despite decades of cancer care, public communication campaigns and prevention techniques there are still many gaps in cancer care at various points within the cancer care continuum from cancer prevention, early detection, diagnosis, treatment, survivorship and end-of life care.

Based on a recent community health needs assessment focused on cancer, it was determined there is a need to improve screening rates for those at-risk for cancer, address psychosocial barriers to screenings and prevention, and make sure the most up-to-date screening information is available and practiced among health care professionals. Addressing these needs and reviewing personalization techniques for care that take into account psychosocial factors will result in more accurate screening recommendations for each patient and improved early cancer detection and prevention. This year the course will specifically focus on lung, gastric and hereditary cancers.

Through didactic lectures, multidisciplinary panels and discussions, this symposium will use lectures and cancer control case examples to review the tools and techniques that can be used by health care professionals to improve screening rates for cancers among at-risk populations, address psychosocial factors affecting compliance and personalization efforts, and lessen confusion about current screening recommendations and prevention guidelines.


M.D./D.O.  $200*
Allied Health Professional (need credit; ARNP, PA, nurses, etc.) $100*
Swedish Employees (no CME/CE credit needed, not in above categories) $50
Community Health Organizations / Patient Advocates $50
Residents/Fellows/Medical Students $25

*After Monday, March 2, please add $30 to Advance Registration pricing.

Registration Information
Pre-registration is required as space is limited. Participants who register by the "Advance Registration" date will receive a reminder email after Monday, March 2, 2020. Registrations will only be processed when accompanied by full payment.

To receive a refund, notice of cancellation must be received no later than Friday, March 6, 2020.

Special Accommodations
If you require specific dietary or physical accommodations, please contact Swedish CME at or 206-386-2755.

Registration Fees
Swedish CME is a self-sustaining unit and does not depend on or receive public monies in support of its educational efforts. The fees for this course includes catering, all instruction materials, wi-fi access, online syllabus access and a certificate of AMA PRA Category 1 Credits™.

The Renaissance Seattle Hotel has limited parking at the venue. Parking will be offered at a conference special of $20/day.  Please see the registration desk before leaving the conference that day.

This symposium is financially supported in part by educational grants in accordance with ACCME’s Standards for Commercial Support. A complete listing of commercial supporters is not available at this time. Appropriate acknowledgment will be given to all supporters at the time of the symposium.


The planning committee gratefully acknowledges the Platinum Level exhibit support for this conference from:


Myriad Genetics

(Additional acknowledgements will be added as confirmed).